Clinical Trials on Restrictive Lung Disease in New Zealand
Total 43953 results
-
Efemoral Medical, Inc.RecruitingVascular Diseases | Peripheral Arterial Disease | Stenosis | Femoropopliteal StenosisNew Zealand, Australia
-
Murdoch Childrens Research InstituteRoyal Children's HospitalCompletedPrimary Immunodeficiency | Invasive Pneumococcal Disease, Protection Against | Invasive Pneumococcal Disease, Recurrent Isolated, 1 | Invasive Pneumococcal Disease, Recurrent Isolated, 2Australia, New Zealand
-
Cordis CorporationConor MedsystemsTerminatedCoronary AtherosclerosisBrazil, New Zealand
-
University of ReadingMassey UniversityCompletedHypertensionNew Zealand
-
Arrowhead PharmaceuticalsRecruitingMyotonic Dystrophy 1New Zealand, Australia
-
NeuroActiva, Inc.Biomed Industries, Inc.UnknownCovid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)New Zealand, United States
-
PolyActiva Pty LtdCompletedOcular Hypertension | Open Angle GlaucomaNew Zealand
-
SurModics, Inc.Active, not recruitingHemodialysis Access FailureAustralia, New Zealand
-
MetaventionCompletedDiabetes | Endocrine, Nutritional and Metabolic Diseases (E00-E89)New Zealand
-
Bristol-Myers SquibbTerminatedTumorItaly, United States, New Zealand
-
Medtronic VascularCompletedUncontrolled HypertensionAustralia, New Zealand
-
Shockwave Medical, Inc.Active, not recruitingPeripheral Arterial DiseaseNew Zealand, Australia
-
Aligos TherapeuticsTerminatedChronic Hepatitis BUnited Kingdom, New Zealand
-
Medtronic Cardiac Rhythm and Heart FailureCompleted
-
Australian and New Zealand Intensive Care Research...Intensive Care Foundation, AustraliaCompletedCritically Ill Adults Ventilated >24 Hours in Intensive CareAustralia, New Zealand
-
Slagelse HospitalOdense University Hospital; Zealand University Hospital; Hvidovre University... and other collaboratorsCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedInfluenza | Orthomyxoviridae Infection | Myxovirus InfectionAustralia, New Zealand
-
Louisiana State University Health Sciences Center...CompletedPhysical Activity | Metabolic Syndrome | Inflammatory Response | Asthma in Children | Obesity, Childhood | Nutrition Poor | Behavior, Eating | Maternal Exposure | Molecular Biology, Restriction Fragment Length Polymorphisms | Genetic ChangeUnited States
-
Hoffmann-La RocheActive, not recruitingMetastatic Melanoma | Non-small Cell Lung Cancer (NSCLC) | Solid Tumors | Esophageal Squamous Cell Carcinoma (ESCC) | Small Cell Lung Cancer (SCLC)United States, Korea, Republic of, Denmark, France, Spain, New Zealand
-
Verve Therapeutics, Inc.Not yet recruitingHypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial HypercholesterolemiaNew Zealand, United Kingdom
-
Verve Therapeutics, Inc.Active, not recruitingHypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial HypercholesterolemiaNew Zealand, United Kingdom
-
Menzies Institute for Medical ResearchYale University; University Medical Center Groningen; University of Southern... and other collaboratorsUnknownBronchopulmonary DysplasiaAustralia, United States, New Zealand, Israel, Slovenia, Turkey
-
MedImmune LLCCompletedRespiratory Syncytial Virus Infections | Chronic Lung Disease and <= 24 Months of Age or | Premature With Gestational Age <=35 Weeks and <=6 Months of AgeAustralia, Chile, New Zealand
-
Neothetics, IncCompletedThyroid-Related Eye DiseaseAustralia, New Zealand
-
AtaCor Medical, Inc.CompletedConduction DefectNew Zealand, Paraguay, Czechia
-
Flinders UniversityCompletedChronic Obstructive Pulmonary Disease | DyspneaAustralia, New Zealand
-
Mundipharma Research LimitedCompletedAsthmaUnited Kingdom, Sweden, Australia, New Zealand, Slovakia
-
Geneos TherapeuticsActive, not recruitingHCCUnited States, New Zealand
-
Alvotech Swiss AGIqvia Pty LtdCompletedPsoriasisAustralia, New Zealand
-
Targovax ASATerminated
-
Kona Medical Inc.CompletedHypertensionCzech Republic, New Zealand
-
Arrow TherapeuticsDDS, Dundee; David Mutimer, Birmingham; Ed Gane, ACS New ZealandTerminatedChronic Hepatitis CNew Zealand, United Kingdom
-
University of Auckland, New ZealandCounties Manukau Health; Auckland Medical Research Foundation; Auckland District... and other collaboratorsUnknown
-
Starship Child Health, Te Toka Tumai AucklandMenzies School of Health Research; Health Research Council, New ZealandNot yet recruitingRheumatic Fever | Sydenham ChoreaAustralia, New Zealand
-
ClarVista MedicalCompletedCataractNew Zealand, Philippines
-
Gilead SciencesCompletedChronic Hepatitis BUnited States, New Zealand
-
James Cook University, Queensland, AustraliaNational Health and Medical Research Council, Australia; The Prince Charles... and other collaboratorsCompleted
-
National University Heart Centre, SingaporeAstraZenecaRecruitingAcute Coronary SyndromeAustralia, New Zealand, Singapore
-
NovartisNovartis PharmaceuticalsCompletedHepatitis BHong Kong, Singapore, New Zealand
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand, United Kingdom
-
MedImmune LLCCompletedRenal InsufficiencyNew Zealand, Germany
-
Hoffmann-La RocheCompleted
-
Antisoma ResearchCompletedMetastatic Renal Cell Carcinoma | Metastatic Malignant MelanomaUnited Kingdom, New Zealand
-
Trans Tasman Radiation Oncology GroupUnknownNon Small Cell Lung CancerAustralia, New Zealand
-
University of SouthamptonNational University Hospital, Singapore; Singapore Institute for Clinical Sciences and other collaboratorsEnrolling by invitationNeurobehavioral Manifestations | Allergy | Microbial Colonization | Growth Disorders | Atopic Dermatitis | Obesity, Childhood | Metabolic Disturbance | Cognition | Lifestyle | Breastfeeding | Nutrition, Healthy | AtopySingapore, United Kingdom, New Zealand
-
Hoffmann-La RocheCompletedHepatitis B, ChronicNew Zealand
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary RestenosisNew Zealand, Denmark, Poland, Netherlands
-
The University of New South WalesTerminatedIschemia | Arterial Occlusive Diseases | Peripheral Arterial Disease (PTANew Zealand, Australia, Netherlands
-
Micell TechnologiesCompletedFirst-In-Human Trial of the MiStent Drug-Eluting Stent (DES) in Coronary Artery Disease (DESSOLVE-I)Coronary Artery DiseaseBelgium, Australia, New Zealand